Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, Extranodal NK-T-Cell × aldesleukin × 1 year × Clear all

Sponsor

Conditions

Melanoma 14 Neoplasm Metastasis 9 Pancreatic Neoplasms 8 Ovarian Neoplasms 8 Stomach Neoplasms 7 Leukemia, Myeloid, Acute 6 Carcinoma, Renal Cell 6 Carcinoma, Non-Small-Cell Lung 6 Skin Neoplasms 5 Colorectal Neoplasms 5 Triple Negative Breast Neoplasms 4 Breast Neoplasms 4 Uterine Cervical Neoplasms 3 Rectal Neoplasms 3 Neuroblastoma 3 Myelodysplastic Syndromes 3 Multiple Myeloma 3 Lymphoma, Non-Hodgkin 3 Leukemia 3 Hematologic Neoplasms 3 Gastrointestinal Neoplasms 3 Colonic Neoplasms 3 Vulvar Neoplasms 2 Urogenital Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Sarcoma 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Neoplasms 2 Lung Neoplasms 2 Leukemia, Myeloid 2

Interventions

pegaspargase 3 tislelizumab 1 sugemalimab 1 relatlimab 1 gemcitabine-oxaliplatin regimen 1 fludarabine phosphate 1 Whole-Body Irradiation 1 Vorinostat 1 Valganciclovir 1 Thiotepa 1 Therapeutics 1 Tacrolimus 1 Sirolimus 1 Radiotherapy 1 Positron-Emission Tomography 1 Polymerase Chain Reaction 1 Peripheral Blood Stem Cell Transplantation 1 Oxaliplatin 1 Nivolumab 1 Mycophenolic Acid 1 Methotrexate 1 Melphalan 1 Immune Checkpoint Inhibitors 1 Ice 1 Gemcitabine 1 Ganciclovir 1 Foscarnet 1 Flow Cytometry 1 Etoposide 1 Cyclosporine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡